Skip to main content
logo
Shield Therapeutics plc (AIM:STX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
5.95
-0.10 (-1.65%)
Oct 2, 2026, 4:43 PM GMT

Shield Therapeutics Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6510521521896
Market Cap Growth
-17.05%395.31%-59.70%186.53%-80.96%28.62%
Enterprise Value
7711631461673
Last Close Price
0.060.100.030.070.070.43

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-113.42113.42113.42113.42113.42
PS Ratio
1.462.830.825.104.0163.24
PB Ratio
-5.04-9.34-20.074.443.372.36
P/TBV Ratio
---4.824.154.11

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
1.753.151.194.503.4848.36

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.46-2.00-20.021.351.040.00
Net Debt / Equity Ratio
-0.97-1.23-15.070.420.52-0.29
Net Debt / EBITDA Ratio
-3.74-1.88-0.89-0.20-0.110.64
Net Debt / FCF Ratio
12.55-5.44-2.92-0.17-0.150.64
Asset Turnover
1.010.810.610.350.140.04
Inventory Turnover
3.543.593.893.651.630.65
Quick Ratio
0.550.670.901.830.623.73
Current Ratio
0.750.901.162.280.954.64
Return on Equity (ROE)
---396.36%-308.60%-179.19%-55.46%
Return on Assets (ROA)
-4.37%-10.24%-26.90%-51.93%-49.37%-32.97%
Return on Capital Employed (ROCE)
-51.40%-66.70%-92.00%-89.40%-229.50%-49.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-12.08%-12.54%-102.83%-49.88%-225.97%-20.48%
FCF Yield
1.54%-2.42%-25.74%-55.98%-102.82%-19.40%
Buyback Yield / Dilution
-16.25%-33.81%-8.33%-209.85%-14.08%-74.36%